dehydroepiandrosterone


Also found in: Medical, Acronyms, Encyclopedia, Wikipedia.
Related to dehydroepiandrosterone: Dehydroepiandrosterone sulfate

de·hy·dro·ep·i·an·dros·te·rone

 (dē′hī-drō-ĕp′ē-ăn-drŏs′tə-rōn′)
n.
DHEA.

dehydroepiandrosterone

(diːˌhaɪdrəʊˌɛpɪænˈdrɒstəˌrəʊn)
n
(Biochemistry) the most abundant steroid in the human body, that is involved in the manufacture of testosterone, oestrogen, progesterone, and corticosterone
Translations

dehydroepiandrosterone (DHEA)

n dehidroepiandrosterona (DHEA)
Mentioned in ?
References in periodicals archive ?
Characterization and measurement of dehydroepiandrosterone sulfate in rat brain.
Women who received oral dehydroepiandrosterone (DHEA) for at least 12 weeks prior to ovarian stimulation had a median of four oocytes retrieved, the same number as those given placebo.
Another RCT found no effect of dehydroepiandrosterone on fatigue in women with inactive SLE.
Researchers from a wide range of medical specialties look at estrogens, progestine, allopregnanoline, and neuroprotection; glucocorticoids, dehydroepiandrosterone, neuroprotection, and neuropathy; polypeptide hormones and neuroprotection;and hormones and neurogenesis.
The July 2010 article "Liquid Chromatography-Tandem Mass Spectrometry Assay for Androstenedione, Dehydroepiandrosterone, and Testosterone with Pediatric and Adult Reference Intervals" by Mark M.
They were looking for the production of a brain hormone called dehydroepiandrosterone (DHEA).
Until now, scientists have known little about this natural steroid, known as dehydroepiandrosterone sulphate - DHEAS - except that levels of it decline sharply with age.
Hormonal assessment included serum levels of prolactin, luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone, and dehydroepiandrosterone (DHEA), by using the radioimmunoassay method (DIAPLUS, USA).
7 October 2010 - Bayer HealthCare Pharmaceuticals, part of German Bayer AG (ETR: BAYN), and Canadian EndoCeutics Inc said on Tuesday they have inked an exclusive collaborative agreement for Phase III development and marketing of Dehydroepiandrosterone (DHEA), a treatment for vaginal atrophy and female sexual dysfunction.